Medicine and Dentistry

1. Patient 100%
2. Neoadjuvant Chemotherapy 86%
3. Neoplasm 83%
4. Adenocarcinoma 61%
5. Surgical Margin 57%
6. Esophageal Adenocarcinoma 57%
7. Hazard Ratio 48%
8. Positron Emission Tomography-Computed Tomography 44%
9. Recurrent Disease 42%
10. Esophageal Cancer 40%
11. Chemotherapy 36%
12. Esophagectomy 34%
13. Lymph Node 33%
14. Stomach Adenocarcinoma 33%
15. Analysis 32%
16. Therapeutic Procedure 30%
17. Neoadjuvant Therapy 30%
18. Esophagus 28%
19. Specimen 26%
20. Esophagus Carcinoma 25%
21. Glucose 25%
22. Chemotherapy Regimens 25%
23. Medical Research 25%
24. PET-MRI 25%
25. Fluorodeoxyglucose F 18 25%
26. Experience 25%
27. Adjuvant Therapy 25%
28. Tumor Regression 24%
29. Adjuvant Chemoradiotherapy 16%
30. Mixed Tumor 14%
31. Proportional Hazards Model 13%
32. Primary Tumor 13%
33. Cohort Analysis 10%
34. Adverse Event 7%
35. Postoperative Complication 7%
36. Survival Analysis 7%
37. Chemoradiotherapy 6%
38. Pathologist 6%
39. Long Term Survival 6%
40. Tumor Recurrence 6%
41. Stomach Tumor 6%
42. Metastatic Carcinoma 5%
43. Hospital 5%
44. Fluorouracil 5%